Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SHREEPUSHK.NS Stock Summary
Top 10 Correlated ETFs
SHREEPUSHK.NS
In the News
SHREEPUSHK.NS Financial details
Company Rating
Buy
Market Cap
5.68B
Income
367.86M
Revenue
7.16B
Book val./share
-
Cash/share
-
Dividend
1.5
Dividend %
0.7%
Employees
553
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
19.63
Forward P/E
-
PEG
-5.53
P/S
0.97
P/B
1.48
P/C
-
P/FCF
-
Quick Ratio
1.22
Current Ratio
1.72
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
11.62
EPS next Y
-
EPS next Q
-
EPS this Y
-34.31%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-2.34%
Revenue last 5Y
8.94%
Revenue Q/Q
-5.71%
EPS Q/Q
-9.74%
-
-
-
-
SMA20
5.92%
SMA50
-11.82%
SMA100
-6.77%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
15%
ROC
0.1%
Gross Margin
37%
Oper. Margin
7%
Profit Margin
5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
155.15-242.0
52W High
-28.68%
52W Low
+11.35%
RSI
47
Rel Volume
0.56
Avg Volume
78.77K
Volume
43.77K
Perf Week
-5.61%
Perf Month
-8.97%
Perf Quarter
-8.07%
Perf Half Y
-21.17%
-
-
-
-
Beta
0.574
-
-
Volatility
4.04%, 8.32%
Prev Close
-1.93%
Price
172.6
Change
-2.32%
SHREEPUSHK.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 145.35 | 111.17 | 114.12 | 188.28 | 217.27 | |
Net income per share | 13.32 | 11.6 | 9.25 | 18.01 | 11.83 | |
Operating cash flow per share | 18.2 | 24.55 | 13.36 | 13.69 | 16.01 | |
Free cash flow per share | 10.71 | 10.62 | 2.72 | -5.24 | 7.64 | |
Cash per share | 12.86 | 0.38 | 2.04 | 27.24 | 30.15 | |
Book value per share | 92.73 | 99.44 | 109.93 | 128.27 | 139 | |
Tangible book value per share | 91.14 | 97.86 | 108.35 | 126.68 | 137.45 | |
Share holders equity per share | 92.73 | 99.44 | 109.93 | 128.27 | 139 | |
Interest debt per share | 16.34 | 17.44 | 19.08 | 31.09 | 22.02 | |
Market cap | 5.1B | 2.26B | 4.22B | 8.64B | 4.67B | |
Enterprise value | 5.57B | 2.78B | 4.78B | 9.46B | 5.3B | |
P/E ratio | 12.49 | 6.34 | 14.8 | 15.56 | 12.53 | |
Price to sales ratio | 1.14 | 0.66 | 1.2 | 1.49 | 0.68 | |
POCF ratio | 9.14 | 3 | 10.26 | 20.47 | 9.26 | |
PFCF ratio | 15.53 | 6.93 | 50.43 | -53.45 | 19.4 | |
P/B Ratio | 1.79 | 0.74 | 1.25 | 2.18 | 1.07 | |
PTB ratio | 1.79 | 0.74 | 1.25 | 2.18 | 1.07 | |
EV to sales | 1.25 | 0.81 | 1.36 | 1.63 | 0.77 | |
Enterprise value over EBITDA | 7.83 | 5.29 | 10.34 | 11.14 | 6.95 | |
EV to operating cash flow | 9.98 | 3.67 | 11.6 | 22.4 | 10.52 | |
EV to free cash flow | 16.95 | 8.5 | 57.03 | -58.49 | 22.04 | |
Earnings yield | 0.08 | 0.16 | 0.07 | 0.06 | 0.08 | |
Free cash flow yield | 0.06 | 0.14 | 0.02 | -0.02 | 0.05 | |
Debt to equity | 0.17 | 0.17 | 0.17 | 0.24 | 0.15 | |
Debt to assets | 0.12 | 0.12 | 0.12 | 0.15 | 0.1 | |
Net debt to EBITDA | 0.66 | 0.98 | 1.2 | 0.96 | 0.83 | |
Current ratio | 2.21 | 1.43 | 1.36 | 1.56 | 1.83 | |
Interest coverage | 19.49 | 24.89 | 33.5 | 48.21 | 22.71 | |
Income quality | 1 | 1.89 | 1.15 | 0.6 | 0.91 | |
Dividend Yield | 0 | 0.03 | 0 | 0 | 0.01 | |
Payout ratio | 0 | 0.21 | 0 | 0.06 | 0.17 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.41 | -0.57 | -0.8 | -1.38 | -0.52 | |
Capex to revenue | -0.05 | -0.13 | -0.09 | -0.1 | -0.04 | |
Capex to depreciation | -2.31 | -3.75 | -2.59 | -4.13 | -1.42 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 166.7 | 161.09 | 151.29 | 228.01 | 192.32 | |
ROIC | 0.13 | 0.1 | 0.06 | 0.1 | 0.07 | |
Return on tangible assets | 0.1 | 0.08 | 0.06 | 0.09 | 0.06 | |
Graham Net | 8.42 | -13.08 | -16.96 | -8.01 | 4.16 | |
Working capital | 1.16B | 467.66M | 417.44M | 1.07B | 1.51B | |
Tangible asset value | 2.8B | 3.01B | 3.34B | 3.91B | 4.33B | |
Net current asset value | 882.93M | 238.91M | 100.8M | 687.75M | 1.13B | |
Invested capital | 0.17 | 0.17 | 0.17 | 0.24 | 0.15 | |
Average receivables | 527.57M | 919M | 795.67M | 898.07M | 1.13B | |
Average payables | 476.8M | 496.94M | 520.77M | 674.87M | 905.56M | |
Average inventory | 722.95M | 621.89M | 587.05M | 734.99M | 871.8M | |
Days sales outstanding | 86.39 | 83.48 | 83.86 | 62.09 | 68.43 | |
Days payables outstanding | 49.04 | 80.7 | 73.04 | 73.71 | 81.13 | |
Days of inventory on hand | 68.07 | 91.91 | 81.4 | 79.19 | 70.04 | |
Receivables turnover | 4.22 | 4.37 | 4.35 | 5.88 | 5.33 | |
Payables turnover | 7.44 | 4.52 | 5 | 4.95 | 4.5 | |
Inventory turnover | 5.36 | 3.97 | 4.48 | 4.61 | 5.21 | |
ROE | 0.14 | 0.12 | 0.08 | 0.14 | 0.09 | |
Capex per share | -7.49 | -13.93 | -10.64 | -18.93 | -8.37 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 48.59 | 57.01 | 55.5 | 58.56 | 55.22 | |
Net income per share | 1.62 | 4.05 | 2.49 | 2.67 | 2.41 | |
Operating cash flow per share | 3.08 | 3.13 | 3.42 | 3.44 | 3.47 | |
Free cash flow per share | 3.08 | 3.13 | 3.42 | 3.44 | 3.47 | |
Cash per share | 32.95 | 30.02 | 29.65 | 40.52 | 0 | |
Book value per share | 132.72 | 138.37 | 138.37 | 143.53 | 0 | |
Tangible book value per share | 0 | 136.83 | 0 | 141.98 | 0 | |
Share holders equity per share | 132.72 | 138.37 | 138.37 | 143.53 | 0 | |
Interest debt per share | 0.14 | 21.53 | 0.16 | 39.66 | 0.19 | |
Market cap | 5.9B | 4.69B | 5.81B | 6.56B | 7.14B | |
Enterprise value | 6.94B | 5.32B | 6.75B | 7.58B | 7.14B | |
P/E ratio | 28.79 | 9.14 | 18.43 | 19.4 | 23.38 | |
Price to sales ratio | 3.84 | 2.6 | 3.31 | 3.54 | 4.09 | |
POCF ratio | 60.57 | 47.35 | 53.69 | 60.35 | 65.09 | |
PFCF ratio | 60.57 | 47.35 | 53.69 | 60.35 | 65.09 | |
P/B Ratio | 1.4 | 1.07 | 1.33 | 1.45 | 0 | |
PTB ratio | 1.4 | 1.07 | 1.33 | 1.45 | 0 | |
EV to sales | 4.51 | 2.95 | 3.85 | 4.1 | 4.09 | |
Enterprise value over EBITDA | 44.76 | 23.73 | 42.39 | 45.11 | 51.17 | |
EV to operating cash flow | 71.28 | 53.77 | 62.35 | 69.79 | 65.09 | |
EV to free cash flow | 71.28 | 53.77 | 62.35 | 69.79 | 65.09 | |
Earnings yield | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Debt to equity | 0 | 0.15 | 0 | 0.28 | 0 | |
Debt to assets | 0 | 0.1 | 0 | 0.18 | 0 | |
Net debt to EBITDA | 6.72 | 2.83 | 5.89 | 6.1 | 0 | |
Current ratio | 0 | 1.83 | 0 | 1.72 | 0 | |
Interest coverage | 24.39 | 18.22 | 17.35 | 49.9 | 13.78 | |
Income quality | 1.9 | 0.77 | 1.37 | 1.29 | 1.44 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 69.53 | 112.31 | 88.11 | 92.9 | 0 | |
ROIC | 0.01 | 0.03 | 0.02 | 0.01 | 0 | |
Return on tangible assets | 0 | 0.02 | 0 | 0.01 | 0 | |
Graham Net | 32.95 | 4.14 | 29.65 | 5.92 | 0 | |
Working capital | 1.04B | 1.51B | 937.84M | 1.59B | 0 | |
Tangible asset value | 0 | 4.33B | 0 | 4.49B | 0 | |
Net current asset value | 1.04B | 1.13B | 937.84M | 1.2B | 0 | |
Invested capital | 0 | 0.15 | 0 | 0.28 | 0 | |
Average receivables | 556.74M | 641.16M | 641.16M | 706.3M | 706.3M | |
Average payables | 302.38M | 478.95M | 478.95M | 412.03M | 412.03M | |
Average inventory | 319.46M | 413.49M | 413.49M | 434.75M | 434.75M | |
Days sales outstanding | 0 | 64.01 | 0 | 68.64 | 0 | |
Days payables outstanding | 0 | 81.98 | 0 | 60.63 | 0 | |
Days of inventory on hand | 0 | 70.78 | 0 | 63.97 | 0 | |
Receivables turnover | 0 | 1.41 | 0 | 1.31 | 0 | |
Payables turnover | 0 | 1.1 | 0 | 1.48 | 0 | |
Inventory turnover | 0 | 1.27 | 0 | 1.41 | 0 | |
ROE | 0.01 | 0.03 | 0.02 | 0.02 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SHREEPUSHK.NS Frequently Asked Questions
What is Shree Pushkar Chemicals & Fertilisers Limited stock symbol ?
Shree Pushkar Chemicals & Fertilisers Limited is a IN stock and trading under the symbol SHREEPUSHK.NS
What is Shree Pushkar Chemicals & Fertilisers Limited stock quote today ?
Shree Pushkar Chemicals & Fertilisers Limited stock price is $172.6 today.
Is Shree Pushkar Chemicals & Fertilisers Limited stock public?
Yes, Shree Pushkar Chemicals & Fertilisers Limited is a publicly traded company.